NASDAQ:OFIX Orthofix Medical (OFIX) Stock Forecast, Price & News $12.40 -0.29 (-2.29%) (As of 09/26/2023 ET) Add Compare Share Share Today's Range$12.38▼$12.7850-Day Range$12.40▼$21.3652-Week Range$12.26▼$23.19Volume585,511 shsAverage Volume724,965 shsMarket Capitalization$455.58 millionP/E RatioN/ADividend YieldN/APrice Target$16.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Orthofix Medical MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside29.0% Upside$16.00 Price TargetShort InterestHealthy1.76% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.41Based on 6 Articles This WeekInsider TradingAcquiring Shares$101,025 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($0.66) to ($0.43) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.30 out of 5 starsMedical Sector289th out of 963 stocksSurgical & Medical Instruments Industry35th out of 98 stocks 3.0 Analyst's Opinion Consensus RatingOrthofix Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $16.00, Orthofix Medical has a forecasted upside of 29.0% from its current price of $12.40.Amount of Analyst CoverageOrthofix Medical has only been the subject of 2 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.76% of the outstanding shares of Orthofix Medical have been sold short.Short Interest Ratio / Days to CoverOrthofix Medical has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Orthofix Medical has recently decreased by 5.96%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldOrthofix Medical does not currently pay a dividend.Dividend GrowthOrthofix Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OFIX. Previous Next 0.9 News and Social Media Coverage News SentimentOrthofix Medical has a news sentiment score of -0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.80 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Orthofix Medical this week, compared to 4 articles on an average week.Search InterestOnly 2 people have searched for OFIX on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Orthofix Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $101,025.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 4.70% of the stock of Orthofix Medical is held by insiders.Percentage Held by Institutions89.76% of the stock of Orthofix Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Orthofix Medical are expected to grow in the coming year, from ($0.66) to ($0.43) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Orthofix Medical is -3.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Orthofix Medical is -3.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOrthofix Medical has a P/B Ratio of 0.74. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Orthofix Medical (NASDAQ:OFIX) StockOrthofix Medical Inc. operates spine and orthopedics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through Global Spine and Global Orthopedics segments. The Global Spine segment comprises the bone growth therapies products, which manufactures and distributes bone growth stimulator devices for enhance of bone fusion including adjunctive and noninvasive treatment of cervical and lumbar spine as well as a therapeutic treatment for non-spine; the spinal implants products designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and the biological products, such as regenerative products and tissue forms which allow physicians to treat a variety of spinal and orthopedic conditions. Global Orthopedics segment offers products and solutions that allow physicians to treat a variety of orthopedic conditions unrelated to the spine, which design, develop, and market the orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. It sells its products through distributors, sales representatives, hospitals, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.Read More OFIX Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OFIX Stock News HeadlinesSeptember 26, 2023 | tmcnet.comROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Orthofix Medical Inc. Investors to Inquire About Securities Class Action Investigation - OFIXSeptember 26, 2023 | finance.yahoo.comImplantable Medical Devices Market to grow by USD 51.1 billion from 2022-2027 | North America to account for 45% of market growth - TechnavioSeptember 27, 2023 | Edge On The Street (Ad)Is Gold Really Boring?Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks. September 22, 2023 | markets.businessinsider.comOrthofix Ongoing Investor AlertSeptember 21, 2023 | finance.yahoo.comOrthofix (OFIX) Unveils Gemini System, Advances in Trauma WingSeptember 20, 2023 | finance.yahoo.comOrthofix Announces First Patient Procedures and Full Commercial Launch of the Galaxy Fixation Gemini System and Expanded Sterile Kit Offerings for Orthopedic Trauma ProceduresSeptember 19, 2023 | markets.businessinsider.comOrthofix Shareholder Action ReminderSeptember 19, 2023 | benzinga.comGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Orthofix Medical Inc. (OFIX) on Behalf of InvestorsSeptember 27, 2023 | Edge On The Street (Ad)Is Gold Really Boring?Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks. September 19, 2023 | businesswire.comGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Orthofix Medical Inc. (OFIX) on Behalf of InvestorsSeptember 15, 2023 | benzinga.comOrthofix Medical Director Trades $101K In Company StockSeptember 15, 2023 | benzinga.comINVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Orthofix Medical Inc. (OFIX) on Behalf of InvestorsSeptember 15, 2023 | finance.yahoo.comDirector James Hinrichs Acquires 7,500 Shares of Orthofix Medical IncSeptember 15, 2023 | businesswire.comORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the FirmSeptember 14, 2023 | technews.tmcnet.comThe Law Offices of Frank R. Cruz Continues Its Investigation of Orthofix Medical Inc. (OFIX) on Behalf of InvestorsSeptember 13, 2023 | benzinga.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Orthofix Medical Inc. - OFIXSeptember 13, 2023 | technews.tmcnet.comINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Orthofix Medical Inc. (OFIX) on Behalf of InvestorsSeptember 13, 2023 | marketwatch.comOrthofix’s stock has worst day in nearly 30 years after 3 top executives are fired for ‘offensive conduct’September 13, 2023 | benzinga.comAdemi LLP Investigates Claims of Securities Fraud against Orthofix Medical Inc.September 13, 2023 | msn.comBTIG Downgrades Orthofix Medical (OFIX)September 13, 2023 | benzinga.comThe Law Offices of Frank R. Cruz Announces Investigation of Orthofix Medical Inc. (OFIX) on Behalf of InvestorsSeptember 12, 2023 | markets.businessinsider.comJMP Securities Sticks to Their Hold Rating for Orthofix (OFIX)September 12, 2023 | benzinga.comInvestigation of Orthofix Medical Inc. (OFIX) Announced by Holzer & Holzer, LLCSeptember 12, 2023 | msn.comOrthofix (NASDAQ: OFIX) Plummets After Leadership ChangesSeptember 12, 2023 | marketwatch.comOrthofix Medical Shares Drop About 16% After Board Ousts Top ExecutivesSeptember 12, 2023 | marketwatch.comOrthofix terminates CEO, CFO and CLO for ‘repeated inappropriate and offensive conduct’September 12, 2023 | markets.businessinsider.comOrthofix Medical Names Catherine Burzik Interim CEO; Appoints Geoffrey Gillespie As Interim CFOSee More Headlines Receive OFIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Orthofix Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address OFIX Company Calendar Last Earnings8/08/2023Today9/27/2023Next Earnings (Estimated)11/02/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:OFIX CUSIPN6748L10 CIK884624 Webwww.orthofix.com Phone(214) 937-2000Fax599 9 461 6978Employees1,092Year Founded1980Price Target and Rating Average Stock Price Forecast$16.00 High Stock Price Forecast$16.00 Low Stock Price Forecast$16.00 Forecasted Upside/Downside+29.0%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($3.66) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-19,750,000.00 Net Margins-19.74% Pretax Margin-19.15% Return on Equity-1.90% Return on Assets-1.38% Debt Debt-to-Equity Ratio0.11 Current Ratio2.82 Quick Ratio1.25 Sales & Book Value Annual Sales$460.71 million Price / Sales0.99 Cash Flow$1.87 per share Price / Cash Flow6.62 Book Value$16.71 per share Price / Book0.74Miscellaneous Outstanding Shares36,740,000Free Float35,012,000Market Cap$455.58 million OptionableOptionable Beta0.85 Social Links 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMs. Catherine M. Burzik M.A. (Age 73)MA, Interim CEO & Chair of the Board Comp: $137.5kMs. Kimberley A. Elting (Age 58)Pres of Global Orthopedics Comp: $766.67kMr. Kevin J. Kenny (Age 58)Pres of Global Spine Bus. Comp: $607.64kMr. Geoffrey C. GillespieVP, Corp. Controller & Interim CFOMr. Roberto DonadelloSr. VP of Global OperationsDr. Frank Vizesi Ph.D.Chief Scientific OfficerMr. Dan E. YarbroughVP of Investor RelationsMs. Puja LeekhaSr. VP, Chief Ethics & Compliance Officer and Interim Chief Legal OfficerMs. Suzanne ArmstrongChief HR OfficerMr. Ehab M. Esmail (Age 51)Sr. VP of Global Quality, Regulatory & Clinical Affairs More ExecutivesKey CompetitorsSurmodicsNASDAQ:SRDXAngioDynamicsNASDAQ:ANGOAccurayNASDAQ:ARAYAlphatecNASDAQ:ATECOraSure TechnologiesNASDAQ:OSURView All CompetitorsInsiders & InstitutionsJames F HinrichsBought 7,500 shares on 9/14/2023Total: $101,025.00 ($13.47/share)Comerica BankBought 267,503 shares on 8/22/2023Ownership: 0.728%Virginia Retirement Systems ET ALBought 24,800 shares on 8/22/2023Ownership: 0.068%Osaic Holdings Inc.Bought 546 shares on 8/21/2023Ownership: 0.034%Legato Capital Management LLCBought 24,925 shares on 8/18/2023Ownership: 0.163%View All Insider TransactionsView All Institutional Transactions OFIX Stock - Frequently Asked Questions Should I buy or sell Orthofix Medical stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" OFIX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OFIX, but not buy additional shares or sell existing shares. View OFIX analyst ratings or view top-rated stocks. What is Orthofix Medical's stock price forecast for 2023? 2 brokerages have issued 12 month price targets for Orthofix Medical's shares. Their OFIX share price forecasts range from $16.00 to $16.00. On average, they predict the company's share price to reach $16.00 in the next twelve months. This suggests a possible upside of 29.0% from the stock's current price. View analysts price targets for OFIX or view top-rated stocks among Wall Street analysts. How have OFIX shares performed in 2023? Orthofix Medical's stock was trading at $20.53 at the beginning of 2023. Since then, OFIX stock has decreased by 39.6% and is now trading at $12.40. View the best growth stocks for 2023 here. When is Orthofix Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023. View our OFIX earnings forecast. How were Orthofix Medical's earnings last quarter? Orthofix Medical Inc. (NASDAQ:OFIX) announced its earnings results on Tuesday, August, 8th. The medical device company reported $0.02 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.67) by $0.69. The medical device company had revenue of $187.02 million for the quarter, compared to the consensus estimate of $183.80 million. Orthofix Medical had a negative net margin of 19.74% and a negative trailing twelve-month return on equity of 1.90%. What ETF holds Orthofix Medical's stock ? Syntax Stratified SmallCap ETF holds 3,764 shares of OFIX stock, representing 0.39% of its portfolio. What guidance has Orthofix Medical issued on next quarter's earnings? Orthofix Medical issued an update on its FY 2023 earnings guidance on Tuesday, August, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $752.00 million-$758.00 million, compared to the consensus revenue estimate of $750.57 million. What is Brad Mason's approval rating as Orthofix Medical's CEO? 32 employees have rated Orthofix Medical Chief Executive Officer Brad Mason on Glassdoor.com. Brad Mason has an approval rating of 73% among the company's employees. What other stocks do shareholders of Orthofix Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Edwards Lifesciences (EW), Gilead Sciences (GILD), Biogen (BIIB), Pfizer (PFE), Exxon Mobil (XOM), Advanced Micro Devices (AMD), bluebird bio (BLUE) and Esperion Therapeutics (ESPR). What is Orthofix Medical's stock symbol? Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX." Who are Orthofix Medical's major shareholders? Orthofix Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (16.30%), Rubric Capital Management LP (6.55%), Segall Bryant & Hamill LLC (5.65%), State Street Corp (4.33%), Dimensional Fund Advisors LP (3.23%) and Paradice Investment Management LLC (2.58%). Insiders that own company stock include Catherine M Burzik, James F Hinrichs, Jon Carl Serbousek, Kevin J Kenny, Kimberley A Elting, Michael E Paolucci, Rice Doug and Shweta Maniar. View institutional ownership trends. How do I buy shares of Orthofix Medical? Shares of OFIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Orthofix Medical's stock price today? One share of OFIX stock can currently be purchased for approximately $12.40. How much money does Orthofix Medical make? Orthofix Medical (NASDAQ:OFIX) has a market capitalization of $455.58 million and generates $460.71 million in revenue each year. The medical device company earns $-19,750,000.00 in net income (profit) each year or ($3.66) on an earnings per share basis. How many employees does Orthofix Medical have? The company employs 1,092 workers across the globe. How can I contact Orthofix Medical? Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The official website for the company is www.orthofix.com. The medical device company can be reached via phone at (214) 937-2000, via email at markquick@orthofix.com, or via fax at 599 9 461 6978. This page (NASDAQ:OFIX) was last updated on 9/27/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orthofix Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.